No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Oppenheimer Maintains BridgeBio Pharma(BBIO.US) With Hold Rating
Oppenheimer Sticks to Its Hold Rating for BridgeBio Pharma (BBIO)
A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $45 to $48
What BridgeBio Pharma, Inc.'s (NASDAQ:BBIO) P/S Is Not Telling You
Strength Seen in BridgeBio Pharma (BBIO): Can Its 16.0% Jump Turn Into More Strength?
Express News | BridgeBio Pharma Inc - Received $500 Mln Upon Acoramidis U.S. Food and Drug Administration Approval